Novel insights into the pathogenesis of diabetic cardiomyopathy and pharmacological strategies 

Targeting the Endothelium to Achieve Cardioprotection 

Polycystin-1 is required for insulin-like growth factor 1-induced cardiomyocyte hypertrophy 

Inhibition of class I histone deacetylases blunts cardiac hypertrophy through TSC2-dependent mTOR repression 

BAG3 regulates total MAP1LC3B protein levels through a translational but not transcriptional mechanism 

Herpudl impacts insulin-dependent glucose uptake in skeletal muscle cells by controlling the Ca2+-calcineurin-Akt axis 

HERPUD1 protects against oxidative stress-induced apoptosis through downregulation of the inositol 1,4,5-trisphosphate receptor 

Basal autophagy protects cardiomyocytes from doxorubicin-induced toxicity 

Calcium transport and signaling in mitochondria 

Therapeutic targeting of autophagy in myocardial infarction and heart failure